Bartlett & Co Wealth Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Other funds holding DXCM
VCM
VPM
Bartlett & Co Wealth Management's DXCM Position: Q1 2026 in Review
Bartlett & Co Wealth Management increased its DexCom (DXCM) stake by 67% in Q1 2026, buying an estimated $139 and bringing the position to 5 shares worth $300. The position accounts for ﹤0.01% of the portfolio, ranked #1189.
Bartlett & Co Wealth Management first reported a position in DXCM in Q4 2020 and has held it in 16 quarters since. The position peaked at $26.7K in Q4 2023. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- Bartlett & Co Wealth Management held 5 shares of DexCom worth $300 as of Q1 2026.
- Bartlett & Co Wealth Management bought 2 DexCom shares in Q1 2026, an estimated $139.
- DexCom made up ﹤0.01% of Bartlett & Co Wealth Management's portfolio in Q1 2026, its #1189 holding.
- Bartlett & Co Wealth Management first reported a position in DexCom in Q4 2020 and has held it in 16 quarters since.
- Bartlett & Co Wealth Management's DexCom position peaked at $26.7K in Q4 2023.
- 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on Bartlett & Co Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.